Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil

Journal of Andrology
Giorgio PomaraCesare Selli

Abstract

Sildenafil is the most prescribed oral agent for patients with erectile dysfunction (ED). Vardenafil is a new phosphodiesterase type 5 (Pde-5) inhibitor that was approved by the US Food and Drug Administration last year to treat patients with ED of various causes. Both of these Pde-5 inhibitors have vasodilating properties and effects on blood pressure (BP), and like nitrates, they work through the nitric oxide cyclic guanosine monophosphate pathway. The aim of this study was to investigate the influence of these Pde-5 inhibitors on BP and heart rate (HR) in normotensive men with ED by a crossover comparison. Thirty-five patients with ED were enrolled to evaluate and compare the effect of sildenafil (50 mg) and vardenafil (10 mg) on BP and HR. At the screening (baseline [B]) visit, sitting systolic blood pressure (B-SBP), diastolic blood pressure (B-DBP), and HR were measured. We performed a multiple administration for both drugs and, therefore, multiple measurements of BP and HR changes, 3 doses a week, on alternate days, late in the afternoon, and on an empty stomach. B-SBP, B-DBP, and HR were recorded before each 50-mg sildenafil dosing and after 30, 60, 120, and 240 minutes. Data were averaged over the 4 time points and com...Continue Reading

References

Jun 1, 1990·The Journal of Urology·M A VickersN Weidner
Jul 2, 1998·International Journal of Impotence Research·A MoralesI H Osterloh
Mar 17, 1999·The American Journal of Cardiology·G JacksonM J Allen

❮ Previous
Next ❯

Citations

Jun 7, 2005·Expert Opinion on Drug Safety·Thorsten Reffelmann, Robert A Kloner
Feb 28, 2007·Vascular Health and Risk Management·Thorsten Reffelmann, Robert A Kloner
Jul 25, 2009·International Journal of Clinical Practice·W Dinsmore
Mar 28, 2008·Current Hypertension Reports·Lorenzo GhiadoniStefano Taddei
Feb 29, 2008·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Konstantinos KontarasZenon S Kyriakides
Aug 21, 2009·Naunyn-Schmiedeberg's Archives of Pharmacology·Alberto J KaumannMaría Luisa Vargas
Nov 14, 2019·British Journal of Pharmacology·Nikolaos TzoumasDavid J Webb
Jul 27, 2005·BJU International·Culley C Carson, Tom F Lue
Aug 4, 2006·Current Hypertension Reports·L Michael Prisant
Nov 11, 2008·Journal of Endocrinological Investigation·G CoronaM Maggi
Jun 9, 2006·International Journal of Impotence Research·E R SchwarzS Rosanio
Jun 24, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Manoli VourvahisJayvant Heera
Aug 6, 2015·International Urology and Nephrology·Baris AfsarMehmet Kanbay
Nov 27, 2008·BJU International·François Giuliano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Homeostasis

Cardiovascular regulation and homeostasis is important in maintaining health and dysfunction may lead to cardiovascular diseases. Nitric oxide and vascular endothelium are one of many molecules involved in the homeostatic mechanism. Here is the latest research on cardiovascular homeostasis.